Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 6Breast Neoplasms 4Neoplasm Metastasis 3Glioma 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neoplasms 2Gliosarcoma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Brain Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Renal Pelvis and Ureter Urothelial Carcinoma 1Rectal Neoplasms 1Pinealoma 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Meningioma 1Medulloblastoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1

Interventions

plerixafor 1adavosertib 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy 1Radiation 1Proton Therapy 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Pinealoma × Surgical Procedures, Operative × Clear all
NCT00003461 2014-08-21

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Duke University

Phase 1/2 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Neuroblastoma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡